Novel Chromatography for Antibody Variants and Recombinant Proteins

Thursday, October 10, 2024 11:45 AM to 12:10 PM · 25 min. (Africa/Abidjan)

Hall 3 - 3F97

Next-Gen Bio

Product Innovation

Information

Developing purification protocols can be challenging for molecules beyond traditional mAbs such as bispecific antibodies, antibody fragments, and other recombinant proteins. Here we cover strategies to help simplify purification of some of these trickier molecules.

This presentation covers:

Aspects of designing a purification process for bispecific antibodies (using MabSelect™ VH3 resin)

A novel affinity chromatography technology (Cytiva™ Protein Select™ resin) for purification of any recombinant protein.

CytivaAt Cytiva, our mission is to advance and accelerate the development of therapeutics. With 15 000 associates in more than 40 countries, we're driven to use our expertise and talent to achieve better flexibility, capacity, and efficiency for our customers. Our broad and deep portfolio of tools and technologies, global scale, and best-in-class service provides critical support from discovery to delivery, for customers spanning researchers, emerging biotech, large-scale biopharma, and contract manufacturers.

Registered attendees

Senior Director Regulatory AffairsEcolab Life Sciences

Novel Chromatography for Antibody Variants and Recombinant Proteins

Information

Registered attendees

Log in

Log in